KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Goodwill & Intangibles (2018 - 2025)

Takeda Pharmaceutical (TAK) has 5 years of Goodwill & Intangibles data on record, last reported at $23.8 billion in Q1 2025.

  • For Q1 2025, Goodwill & Intangibles fell 34.8% year-over-year to $23.8 billion; the TTM value through Mar 2025 reached $23.8 billion, down 34.8%, while the annual FY2025 figure was $23.8 billion, 36.45% down from the prior year.
  • Goodwill & Intangibles reached $23.8 billion in Q1 2025 per TAK's latest filing, down from $36.5 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $36.9 billion in Q1 2021 and bottomed at $23.8 billion in Q1 2025.
  • Average Goodwill & Intangibles over 3 years is $32.4 billion, with a median of $36.5 billion recorded in 2024.
  • Peak YoY movement for Goodwill & Intangibles: rose 0.21% in 2021, then plummeted 34.8% in 2025.
  • A 3-year view of Goodwill & Intangibles shows it stood at $36.9 billion in 2021, then decreased by 1.15% to $36.5 billion in 2024, then tumbled by 34.8% to $23.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $23.8 billion in Q1 2025, $36.5 billion in Q1 2024, and $36.9 billion in Q1 2021.